BDNF levels and liver stiffness in subjects with alcohol use disorder: Evaluation after alcohol withdrawal

References

• Koskela M, Bäck S, Võikar V, Richie CT, Domanskyi A, Harvey BK, Airavaara M. Update of neurotrophic factors in neurobiology of addiction and future directions. Neurobiol Dis. 2017;97:189–200. doi:10.1016/j.nbd.2016.05.010.
   PubMed Web of Science ®Google Scholar
• Ron D, Berger A. Targeting the intracellular signaling « STOP » and « GO » pathways for the treatment of alcohol use disorders. Psychopharmacol (Berl). 2018;235:1727–1743.
   PubMed Web of Science ®Google Scholar
• Geoffroy H, Noble F. BDNF during withdrawal. Vitam Horm. 2017;104:475–496.
   PubMed Web of Science ®Google Scholar
• Logrip ML, Barak S, Warnault V, Ron D. Corticostriatal BDNF and alcohol addiction. Brain Res. 2015;1628:60–67. doi:10.1016/j.brainres.2015.03.025.
   PubMed Web of Science ®Google Scholar
• Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004;22:123–31. doi:10.1080/08977190410001723308.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Gurney ME. Human platelets contain brain-derived neurotrophic factor. J Neurosci. 1990;10:3469–78. doi:10.1523/JNEUROSCI.10-11-03469.1990.
   PubMed Web of Science ®Google Scholar
• Thoenen H, Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci. 2002;5:1046–50. doi:10.1038/nn938.
   PubMed Web of Science ®Google Scholar
• Ornell F, Hansen F, Schuch FB, Pezzini Rebelatto F, Tavares AL, Scherer JN, Valerio AG, Pechansky F, Paim Kessler FH, von Diemen L. Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis. Drug Alcohol Depend. 2018;193:91–103. doi:10.1016/j.drugalcdep.2018.08.036.
   PubMed Web of Science ®Google Scholar
• Joe KH, Kim YK, Kim TS, Roh SW, Choi SW, Kim YB, Lee HJ, Kim DJ. Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence. Alcohol Clin Exp Res. 2007;31:1833–38. doi:10.1111/j.1530-0277.2007.00507.x.
   PubMed Web of Science ®Google Scholar
• Lee BC, Choi IG, Kim YK, Ham BJ, Yang BH, Roh S, Choi J, Lee JS, Oh DY, Chai YG. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. Alcohol. 2009;43:265–69. doi:10.1016/j.alcohol.2009.04.003.
   PubMed Web of Science ®Google Scholar
• Zanardini R, Fontana A, Pagano R, Mazzaro E, Bergamasco F, Romagnosi G, Gennarelli M, Bocchio-Chiavetto L. Alterations of brain derived neurotrophic factor serum levels in patients with alcohol dependence. Alcohol Clin Exp Res. 2011;35:1529–33.
   PubMed Web of Science ®Google Scholar
• Huang MC, Chen CH, Chen CH, Liu SC, Ho CJ, Shen WW, Leu SJ. Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol. 2008;43:241–45. doi:10.1093/alcalc/agm172.
   PubMed Web of Science ®Google Scholar
• Heberlein A, Muschler M, Wilhelm J, Frieling H, Lenz B, Gröschl M, Kornhuber J, Bleich S, Hillemacher T. BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1060–64. doi:10.1016/j.pnpbp.2010.05.025.
   PubMed Web of Science ®Google Scholar
• Heberlein A, Lenz B, Opfermann B, Gröschl M, Janke E, Stange K, Groh A, Kornhuber J, Frieling H, Bleich S, et al. Association of testosterone and BDNF serum levels with craving during alcohol withdrawal. Alcohol. 2016;54:67–72.
   PubMed Web of Science ®Google Scholar
• Girard M, Labrunie A, Malauzat D, Nubukpo P. Evolution of BDNF serum levels during the first six months after alcohol withdrawal. World J Biol Psychiatry. 2020;6:1–9. doi:10.1080/15622975.2020.1733079.
   Web of Science ®Google Scholar
• Nubukpo P, Ramoz N, Girard M, Malauzat D, Gorwood P. Determinants of blood brain-derived neurotrophic factor blood levels in patients with alcohol use disorder. Alcohol Clin Exp Res. 2017;41:1280–1287. doi:10.1111/acer.13414.
   PubMed Web of Science ®Google Scholar
• Marosi K, Mattson MP. Hold the salt: vasopressor role for BDNF. Cell Metab. 2015;21:509–510. doi:10.1016/j.cmet.2015.03.015.
   PubMed Web of Science ®Google Scholar
• Pius-Sadowska E, Machaliński B. BDNF - A key player in cardiovascular system. J Mol Cell Cardiol. 2017;110:54–60. doi:10.1016/j.yjmcc.2017.07.007.
   PubMed Web of Science ®Google Scholar
• Jin Y, Sun LH, Yang W, Cui RJ, Xu SB. The role of BDNF in the neuroimmune axis regulation of mood disorders. Front Neurol. 2019;10:515. doi:10.3389/fneur.2019.00515.
   PubMed Web of Science ®Google Scholar
• Lima Giacobbo B, Doorduin J, Klein HC, Dierckx RAJO, Bromberg E, de Vries EFJ. Brain-Derived Neurotrophic Factor in Brain Disorders: focus on Neuroinflammation. Mol Neurobiol. 2019;56:3295–3312.
   PubMed Web of Science ®Google Scholar
• Fargali S, Sadahiro M, Jiang C, Frick AL, Indall T, Cogliani V, Welagen J, Lin WJ, Salton SR. Role of neurotrophins in the development and function of neural circuits that regulate energy homeostasis. J Mol Neurosci. 2012;48:654–659. doi:10.1007/s12031-012-9790-9.
   PubMed Web of Science ®Google Scholar
• Genzer Y, Chapnik N, Froy O. Effect of brain-derived neurotrophic factor (BDNF) on hepatocyte metabolism. Int J Biochem Cell Biol. 2017;88:69–74. doi:10.1016/j.biocel.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Yang ZF, Ho DW, Lau CK, Tam KH, Lam CT, Poon RTP, Fan ST. Platelet activation during tumor development, the potential role of BDNF-TrkB autocrine loop. Biochem Biophys Res Commun. 2006;346:981–985. doi:10.1016/j.bbrc.2006.06.007.
   PubMed Web of Science ®Google Scholar
• Yang B, Ren Q, Zhang JC, Chen QX, Hashimoto K. Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis. Transl Psychiatry. 2017;7:e1128. doi:10.1038/tp.2017.95.
   PubMed Web of Science ®Google Scholar
• Dhanda S, Gupta S, Halder A, Sunkaria A, Sandhir R. Systemic inflammation without gliosis mediates cognitive deficits through impaired BDNF expression in bile duct ligation model of hepatic encephalopathy. Brain Behav Immun. 2018;70:214–32. doi:10.1016/j.bbi.2018.03.002.
   PubMed Web of Science ®Google Scholar
• European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237–64. doi:10.1016/j.jhep.2015.04.006.
   PubMed Web of Science ®Google Scholar
• Poynard T, Aubert A, Bedossa P, Abella A, Naveau S, Paraf F, Chaput JC. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology. 1991;100:1397–402.
   PubMed Web of Science ®Google Scholar
• Grant KA, Tonigan JS, Miller WR. Comparison of three alcohol consumption measures: a concurrent validity study. J Stud Alcohol. 1995;56:168–172.
   PubMed Web of Science ®Google Scholar
• Cervantes EA, Miller WR, Tonigan JS. Comparison of timeline follow-back and averaging methods for quantifying alcohol consumption in treatment. Res Assessment. 1994;1:23–30. doi:10.1177/1073191194001001004.
   PubMedGoogle Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi:10.1001/archpsyc.1961.01710120031004.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. 1984;40:1365–1367. doi:10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D.
   PubMed Web of Science ®Google Scholar
• McPherson A, Martin CR. Is the Hospital Anxiety and Depression Scale (HADS) an appropriate screening tool for use in an alcohol-dependent population? J Clin Nurs. 2011;20:1507–1517. doi:10.1111/j.1365-2702.2010.03514.x.
   PubMed Web of Science ®Google Scholar
• Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Fouchard-Hubert I, Gallois Y, Oberti F, Bertrais S, et al. Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57:1182–1191. doi:10.1002/hep.25993.
   PubMed Web of Science ®Google Scholar
• Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, Bedossa P. FIBROSTIC study group. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol. 2010;53:1013–1021. doi:10.1016/j.jhep.2010.05.035.
   PubMed Web of Science ®Google Scholar
• Nguyen-Khac E, Thiele M, Voican C, Nahon P, Moreno C, Boursier J, Mueller S, de Ledinghen V, Stärkel P, Gyune Kim S, et al. Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2018;3:614–25. doi:10.1016/S2468-1253(18)30124-9.
   PubMed Web of Science ®Google Scholar
• Chen CC, Hsu LW, Nakano T, Goto S, Chen CL. Elevation of C-reactive protein level and its correlation with psychiatric comorbidities in recipients after liver transplantation. Transplant Proc. 2014;46:894–896. doi:10.1016/j.transproceed.2013.12.030.
   PubMed Web of Science ®Google Scholar
• Mendez-David I, Hen R, Gardier AM, David DJ. Adult hippocampal neurogenesis: an actor in the antidepressant-like action. Ann Pharm Fr. 2013;71:143–49. doi:10.1016/j.pharma.2013.02.006.
   PubMedGoogle Scholar
• Björkholm C, Monteggia LM. BDNF - a key transducer of antidepressant effects. Neuropharmacology. 2016;102:72–79. doi:10.1016/j.neuropharm.2015.10.034.
   PubMed Web of Science ®Google Scholar
• Carrier P, Girard M, Debette-Gratien M, Ouedraogo N, Loustaud-Ratti V, Nubukpo P. Liver elastometry and alcohol withdrawal: median-term follow-up in a psychiatric unit. Alcohol. 89:49–56. doi:10.1016/j.alcohol.2020.07.007.
   Web of Science ®Google Scholar
• Jo YH, Chua SC. The brain-liver connection between BDNF and glucose control. Diabetes. 2013;62:1367–1368. doi:10.2337/db12-1824.
   PubMed Web of Science ®Google Scholar
• Meek TH, Wisse BE, Thaler JP, Guyenet SJ, Matsen ME, Fischer JD, Taborsky GJ Jr, Schwartz MW, Morton GJ. BDNF action in the brain attenuates diabetic hyperglycemia via insulin-independent inhibition of hepatic glucose production. Diabetes. 2013;62:1512–1518. doi:10.2337/db12-0837.
   PubMed Web of Science ®Google Scholar
• de Timary P, Stärkel P, Delzenne NM, Leclercq S. A role for the peripheral immune system in the development of alcohol use disorders? Neuropharmacol. 2017;122:148–160. doi:10.1016/j.neuropharm.2017.04.013.
   PubMed Web of Science ®Google Scholar
• Zhang JC, Yao W, Hashimoto K. Brain-derived Neurotrophic Factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Curr Neuropharmacol. 2016;14:721–31. doi:10.2174/1570159X14666160119094646.
   PubMed Web of Science ®Google Scholar
• Noren Hooten N, Ejiogu N, Zonderman AB, Evans MK. Protective effects of BDNF against C-Reactive protein-induced inflammation in women. Mediators Inflamm. 2015;2015:516783. doi:10.1155/2015/516783.
   Web of Science ®Google Scholar
• Chen JJ, Wang T, An CD, Jiang CY, Zhao J, Li S. Brain-derived neurotrophic factor: a mediator of inflammation-associated neurogenesis in Alzheimer’s disease. Rev Neurosci. 2016;27:793–811.
   PubMed Web of Science ®Google Scholar
• Chen SD, Wu CL, Hwang WC, Yang DI. More Insight into BDNF against Neurodegeneration: anti-Apoptosis, Anti-Oxidation, and Suppression of Autophagy. Int J Mol Sci. 2017;18:pii: E545. doi:10.3390/ijms18030545.
   Web of Science ®Google Scholar
• Eyileten C, Kaplon-Cieslicka A, Mirowska-Guzel D, Malek L, Postula M. Antidiabetic effect of brain-derived neurotrophic factor and its association with inflammation in Type 2 diabetes mellitus. J Diabetes Res. 2017;2017:2823671. doi:10.1155/2017/2823671.
   PubMed Web of Science ®Google Scholar
• Papathanassoglou ED, Miltiadous P, Karanikola MN. May BDNF be implicated in the exercise-mediated regulation of inflammation? Critical review and synthesis of evidence. Biol Res Nurs. 2015;17:521–39. doi:10.1177/1099800414555411.
   PubMed Web of Science ®Google Scholar
• Neupane SP, Lien L, Ueland T, Mollnes TE, Aukrust P, Bramness JG. Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders. Alcohol. 2015;49:471–78. doi:10.1016/j.alcohol.2015.01.012.
   PubMed Web of Science ®Google Scholar
• Calabrese F, Rossetti AC, Racagni G, Gass P, Riva MA, Molteni R. Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci. 2014;8:430. doi:10.3389/fncel.2014.00430.
   PubMed Web of Science ®Google Scholar
• Duvigneau JC, Luís A, Gorman AM, Samali A, Kaltenecker D, Moriggl R, Kozlov AV. Crosstalk between inflammatory mediators and endoplasmic reticulum stress in liver diseases. Cytokine. 2019;24:154577. doi:10.1016/j.cyto.2018.10.018.
   Web of Science ®Google Scholar
• Xiong J, Liu T, Mi L, Kuang H, Xiong X, Chen Z, Li S, Lin JD. hnRNPU/TrkB defines a chromatin accessibility checkpoint for liver injury and NASH pathogenesis. Hepatol. 2019. doi:10.1002/hep.30921.
   Web of Science ®Google Scholar
• Petta S, Wong VW, Cammà C, Hiriart JB, Wong GL, Marra F, Vergniol J, Chan AW, Di Marco V, Merrouche W, et al. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. Hepatology. 2017;65:1145–55. doi:10.1002/hep.28843.
   PubMed Web of Science ®Google Scholar
• Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterol. 2019;156:1717–30. doi:10.1053/j.gastro.2019.01.042.
   PubMed Web of Science ®Google Scholar
• Trabut JB, Thépot V, Nalpas B, Lavielle B, Cosconea S, Corouge M, Vallet-Pichard A, Fontaine H, Mallet V, Sogni P, et al. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res. 2012;36:1407–1411. doi:10.1111/j.1530-0277.2012.01737.x.
   PubMed Web of Science ®Google Scholar
• Bardou-Jacquet E, Legros L, Soro D, Latournerie M, Guillygomarc’h A, Le Lan C, Brissot P, Guyader D, Moirand R. Effect of alcohol consumption on liver stiffness measured by transient elastography. World J Gastroenterol. 2013;19:516–522. doi:10.3748/wjg.v19.i4.516.
   PubMed Web of Science ®Google Scholar
• Lahmek P, Meunier N, Michel L, Aubin HJ, Balester-Mouret S. Using transient elastography as a screening tool for liver fibrosis in addiction service. Presse Med. 2014;43:e17–31. doi:10.1016/j.lpm.2013.07.027.
   PubMedGoogle Scholar
• Mueller S, Seitz HK, Rausch V. Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterol. 2014;20:14626–41. doi:10.3748/wjg.v20.i40.14626.
   PubMed Web of Science ®Google Scholar
• García-Marchena N, Silva-Peña D, Martín-Velasco AI, Villanúa MÁ, Araos P, Pedraz M, Maza-Quiroga R, Romero-Sanchiz P, Rubio G, Castilla-Ortega E, et al. Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders. PLoS One. 2017;12:e0187634. doi:10.1371/journal.pone.0187634.
   PubMed Web of Science ®Google Scholar
• Ghitza UE, Zhai H, Wu P, Airavaara M, Shaham Y, Lu L. Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev. 2010;35:157–71. doi:10.1016/j.neubiorev.2009.11.009.
   PubMed Web of Science ®Google Scholar